Alere LLC Company Profile

00:50 EDT 24th September 2017 | BioPortfolio

NCQA is a private, non-profit organization dedicated to improving health care quality. NCQA accredits and certifies a wide range of health care organizations and recognizes physicians in key clinical areas. NCQA's HEDIS is the most widely used performance measurement tool in health care. NCQA is committed to providing health care quality information through the Web and media in order to help consumers, employers and others make more informed health care choices.

News Articles [69 Associated News Articles listed on BioPortfolio]

Alere Launches Alere iCup Rx Drug Screen For Detecting Commonly Misused And Abused Prescription Drugs

  Life Sciences Jobs   ...

$5.3B Abbott merger deal secures Alere shareholder approval

An amended merger agreement between Abbott Laboratories and Alere, valued at approximately $5.3 billion, has been approved by -More- 

Alere to Attend the 31st Annual J.P. Morgan Healthcare Conference on January 9, 2013

WALTHAM, Mass., Dec. 28, 2012 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health ...

Alere Enhances Board of Directors With Appointment Of Gregg J. Powers

WALTHAM, Mass., Aug. 22, 2013 /PRNewswire/ -- Alere Inc. (NYSE: ALR) (the "Company" or "Alere") is pleased to announce that on August 19, 2013 its Board of Directors appointed Mr. Gregg J. Powers ...

Alere Inc. Schedules Conference Call for 8:30 a.m. ET February 8, 2012 to Discuss Fourth Quarter 2011 Results

WALTHAM, Mass., Feb. 1, 2012 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h...

Tender offer for Alere shares initiated by Abbott

A tender offer for all outstanding shares of Alere's Series B convertible perpetual preferred stock has been launched by Abbo -More- 

Alere subsidiary to be acquired by Siemens Healthineers

Siemens Healthineers has agreed to pay an undisclosed amount for Alere's point-of-care blood diagnostics subsidiary, Epocal.  -More- 

Alere's Triage assets to be acquired by Quidel in $440M deal

Quidel has agreed to pay $400 million plus $40 million in contingent consideration for Alere's Triage MeterPro cardiovascular -More- 

Drugs and Medications [0 Results]


PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Evaluation of two novel chemiluminescence immunoassays for the detection of Clostridium difficile glutamate dehydrogenase and toxin A&B.

A novel immunoassay for Clostridium difficile glutamate dehydrogenase (GDH) and toxin A&B (LIAISON, DiaSorin) was compared to another GDH assay (Alere), PCR and toxigenic culture. The GDH-DiaSorin is ...

The fourth generation Alere(TM) HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples.

Early and accurate detection of HIV is crucial when using pre-exposure prophylaxis (PrEP) for HIV prevention to avoid PrEP initiation in acutely infected individuals and to minimize the risk of drug r...

Evaluation of two 4th generation point-of-care assays for the detection of Human Immunodeficiency Virus infection.

Fourth generation assays detect simultaneously antibodies for HIV and the p24 antigen, identifying HIV infection earlier than previous generation tests. Previous studies have shown that the Alere Dete...

A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa.

The Global Programme to Eliminate Lymphatic Filariasis uses point-of-care tests for circulating filarial antigenemia (CFA) to map endemic areas and for monitoring and evaluating the success of mass dr...

Evaluation of the Triage TOX Drug Screen Assay for Detection of 11 Drugs of Abuse and Therapeutic Drugs.

The demand for rapid and broad clinical toxicology screens is on the rise. Recently, a new rapid toxicology screening test, the Triage TOX Drug Screen (Alere Inc., USA), which can simultaneously detec...

Clinical Trials [9 Associated Clinical Trials listed on BioPortfolio]

Alere COMBO and Alere q Detect in an HIV PrEP Program in Thailand

Two new rapid HIV tests by Alere™ have the potential to substantially decrease the window period for rapid tests. First, the Alere™ HIV Combo is a rapid fourth generation test. The per...

Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Versus Xpert Flu/RSV

The rapid and accurate detection of influenza virus in respiratory specimens is required for optimal management of patients with acute respiratory infections. Because of the variability of...

Point of Care Virologic Testing to Improve Outcomes of HIV-Infected Children

This is a two-arm, unmasked, randomized, controlled trial to test the effectiveness of the Alere Q point-of-care (POC) HIV diagnostic assay for use in resource-poor settings.

Diagnosis of HIV and Early Antiretroviral Therapy Initiation Among HIV-1 Infected Infants

The purpose of the study is to test the effect of the Alere™ q HIV-1/2 Detect (diagnostic assay) on uptake of HIV testing among HIV-exposed infants and young children, and health outcome...

Impact of Rapid Detection of MRSA

The objective of this study is to evaluate the impact of the Alere™ PBP2a test combined with pharmacist review of antimicrobial therapy, on clinical outcomes and cost in hospitalized...

Companies [9 Associated Companies listed on BioPortfolio]

Alere Inc.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life ...

Alere, LLC

Alere ( is a wholly-owned subsidiary of Inverness Medical Innovations, Inc. ( (NYSE: IMA). Alere, a Latin verb, meaning "to care for" or "to support", offers the...

Alere Health

Alere Health ( is a wholly-owned subsidiary of Inverness Medical Innovations, Inc. ( (NYSE: IMA). Alere, a Latin verb, meaning "to care for" or "to support", off...

Alere Health, LLC

Alere Health, LLC ( is a wholly-owned subsidiary of Inverness Medical Innovations, Inc. ( (NYSE: IMA). Alere, a Latin verb, meaning "to care for" or "to support"...

Alere Analytics

Alere Analytics, formerly DiagnosisOne, provides the healthcare industry with unparalleled analytics and clinical decision support tools based on a single platform. The companyâ...

More Information about "Alere LLC" on BioPortfolio

We have published hundreds of Alere LLC news stories on BioPortfolio along with dozens of Alere LLC Clinical Trials and PubMed Articles about Alere LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alere LLC Companies in our database. You can also find out about relevant Alere LLC Drugs and Medications on this site too.

Quick Search

Relevant Topic

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Corporate Database Quicklinks

Searches Linking to this Company Record